Evidence Hub

Managing High-Cost, Technology-Dependent Therapies: Systems for Cellular, Gene, and Advanced Biologics—A Narrative Review

Abdullah Abdulaziz Ibrahim Alghamdi, Andualrhman Hamad Jaafari, Bander Almalki, Abdulrhnan Saad Aldawsari, Noor Mohammed Omar Usman, Ashwag Ibrahim Majrashi, Yahya Galib M. Qadhy, Ahmed Mohammed Abu Zibnah et al.

Saudi Journal of Medicine and Public Health, 2024

Abstract

Background: The advent of advanced therapy medicinal products (ATMPs), including chimeric antigen receptor T-cell (CAR-T) therapies, in vivo gene therapies, and complex biologics, represents a paradigm shift in treating cancer, genetic disorders, and autoimmune diseases. These "living drugs" and sophisticated molecules present unprecedented challenges, requiring a complete re-engineering of traditional healthcare delivery pathways. Aim: This narrative review synthesizes evidence from 2010-2024 on the integrated, multidisciplinary systems required to safely, effectively, and sustainably manage the clinical and operational lifecycle of high-cost, technology-dependent therapies. Methods: A comprehensive search of PubMed, Scopus, Web of Science, and health policy databases was conducted for peer-reviewed literature and gray literature (white papers, health system reports) addressing the operational, financial, and clinical coordination of advanced therapies. Results: The review identifies five critical, interdependent system pillars: (1) a robust pre-treatment patient and product pathway spanning biomarker screening, cell collection, and manufacturing; (2) a specialized pharmacy and logistics infrastructure for storage, handling, and chain of custody; (3) protocolized clinical delivery and toxicity management anchored by specialized nursing; (4) complex financial navigation and reimbursement models; and (5) coordinated scheduling and data management. Failures in any pillar risk…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free